{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:40:21Z","timestamp":1788306021491,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.nmd.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T02:04:43Z","timestamp":1569377083000},"page":"903-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical features of Pompe disease with motor neuronopathy"],"prefix":"10.1016","volume":"29","author":[{"given":"Li-Kai","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2019.09.011_bib0001","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2019.09.011_bib0002","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.nmd.2019.09.011_bib0003","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/physiolgenomics.00075.2016","article-title":"Transcriptome assessment of the Pompe (Gaa-\/-) mouse spinal cord indicates widespread neuropathology","volume":"48","author":"Turner","year":"2016","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.nmd.2019.09.011_bib0004","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1007\/s12035-017-0763-4","article-title":"A neuron-specific gene therapy relieves motor deficits in Pompe disease mice","volume":"55","author":"Lee","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.nmd.2019.09.011_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/mt.2011.214","article-title":"Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice","volume":"20","author":"Qiu","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2019.09.011_bib0006","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.nmd.2019.09.011_bib0007","first-page":"379","article-title":"Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings","volume":"27","author":"Teng","year":"2004","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.nmd.2019.09.011_bib0008","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.57.5.906","article-title":"Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2","volume":"57","author":"Martini","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.09.011_bib0009","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"eRuisseau","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2019.09.011_bib0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.24433","article-title":"Correcting neuromuscular deficits with gene therapy in Pompe disease","volume":"78","author":"Todd","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2019.09.011_bib0011","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/hmg\/ddu476","article-title":"Peripheral nerve and neuromuscular junction pathology in Pompe disease","volume":"24","author":"Falk","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2019.09.011_bib0012","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2019.09.011_bib0013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases","volume":"27","author":"Desnick","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2019.09.011_bib0014","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.nmd.2019.09.011_bib0015","series-title":"Neurology in clinical practice: principles of diagnosis and management","first-page":"2045","author":"Bradley","year":"2000"},{"key":"10.1016\/j.nmd.2019.09.011_bib0016","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.clinph.2011.04.016","article-title":"The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings","volume":"122","author":"Hobson-Webb","year":"2011","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2019.09.011_bib0017","series-title":"Electromyography and neuromuscular disorders: clinical-electrophysiologic correlations","first-page":"125","author":"Preston","year":"2013"},{"key":"10.1016\/j.nmd.2019.09.011_bib0018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.410020204","article-title":"The ultrastructure of the sural nerve in Pompe's disease","volume":"2","author":"Goebel","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2019.09.011_bib0019","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619311319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619311319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:27Z","timestamp":1760774967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896619311319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0960896619311319"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.09.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features of Pompe disease with motor neuronopathy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}